EP Live

EPLive is a 2 day intensive educational meeting targeting practicing electrophysiologist as well as fellows in training. The meeting consists of four sections: AF ablation, VT ablation, Devices and new technologies. In addition, a panel of recognized experts will provide commentary and discussion.Ā  Previously recorded cases will also be shown.Ā Ā 

Siemens Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Biograph Horizon positron emission tomography/computed tomography (PET/CT) system, which offers premium performance at a low total cost of ownership.

Siemens Healthcare announced that the U.S. Food and Drug Administration (FDA) has cleared the Magnetom Amira 1.5 Tesla magnetic resonance imaging (MRI) system.

This case study is from the Cardiac Imaging Department, Hospital Clinic, Barcelona, Spain. A woman in her early 60s came to the emergency room with left hemiparesis andĀ her medical history suggested several reasons for concern.Ā She was a sufferer of rheumatic valve disease since childhood and had a history of valve surgeries. They used 3-D echo to clearly identify a small thrombus covering part of the prosthetic ring, which had not been completely clear in the 2-D echo.

GE Healthcare is taking the next leap in image quality performance, quantification and workflow with the introduction of a new generation scanners designed around and built upon GEā€™s new software-based beamformer platform, cSound. The Vivid S70, Vivid E90 and Vivid E95 systems all are designed around this cSound platform.Ā 

Download the PDF to read more.

On the 100th anniversary of the Endurance expedition to Antarctica led by Sir Ernest Shackleton, doctors writing in the Journal of the Royal Society of Medicine believe the explorer may have had the congenital defect commonly known as a 'hole in the heart'.

Patients enrolled in high-deductible health insurance plans have lower rates of use and lower costs for imaging tests, suggests a study in the February issue of Medical Care.

At the beginning of each year, I always try to determine what the next big cardiovascular technology advances to watch will be in the coming 12 months. Ā I did not have to look far, as the U.S. Food and Drug Administration (FDA) has pretty much outlined four of these advances with recent meeting notices and approval of a new clinical trial.Ā 

Subscribe to
Ā© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now